Free Trial
NASDAQ:GERN

Geron (GERN) Stock Price, News & Analysis

Geron logo
$1.44 +0.05 (+3.60%)
Closing price 07/9/2025 04:00 PM Eastern
Extended Trading
$1.45 +0.01 (+0.69%)
As of 07:28 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Geron Stock (NASDAQ:GERN)

Key Stats

Today's Range
$1.39
$1.48
50-Day Range
$1.19
$1.62
52-Week Range
$1.17
$5.06
Volume
9.92 million shs
Average Volume
11.24 million shs
Market Capitalization
$917.16 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.06
Consensus Rating
Moderate Buy

Company Overview

Geron Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
57th Percentile Overall Score

GERN MarketRank™: 

Geron scored higher than 57% of companies evaluated by MarketBeat, and ranked 438th out of 920 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Geron has received a consensus rating of Moderate Buy. The company's average rating score is 2.78, and is based on 5 buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Geron has only been the subject of 1 research reports in the past 90 days.

  • Read more about Geron's stock forecast and price target.
  • Earnings Growth

    Earnings for Geron are expected to grow in the coming year, from ($0.25) to ($0.07) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Geron is -6.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Geron is -6.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Geron has a P/B Ratio of 3.13. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Geron's valuation and earnings.
  • Percentage of Shares Shorted

    11.06% of the float of Geron has been sold short.
  • Short Interest Ratio / Days to Cover

    Geron has a short interest ratio ("days to cover") of 5.4.
  • Change versus previous month

    Short interest in Geron has recently increased by 1.01%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Geron does not currently pay a dividend.

  • Dividend Growth

    Geron does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    11.06% of the float of Geron has been sold short.
  • Short Interest Ratio / Days to Cover

    Geron has a short interest ratio ("days to cover") of 5.4.
  • Change versus previous month

    Short interest in Geron has recently increased by 1.01%, indicating that investor sentiment is decreasing.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Geron this week, compared to 12 articles on an average week.
  • Search Interest

    Only 8 people have searched for GERN on MarketBeat in the last 30 days. This is a decrease of -43% compared to the previous 30 days.
  • MarketBeat Follows

    11 people have added Geron to their MarketBeat watchlist in the last 30 days. This is an increase of 57% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Geron insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 7.42% of the stock of Geron is held by insiders.

  • Percentage Held by Institutions

    73.71% of the stock of Geron is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Geron's insider trading history.
Receive GERN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Geron and its competitors with MarketBeat's FREE daily newsletter.

GERN Stock News Headlines

The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump could be just weeks away. And it holds the potential to trigger one of the most explosive tech booms in US history. At the center of it all? Robots. Not the kind that clean your house or pour you coffee. But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year.
Geron Q1 2025: RYTELO-Wachstumspläne
See More Headlines

GERN Stock Analysis - Frequently Asked Questions

Geron's stock was trading at $3.54 at the beginning of 2025. Since then, GERN shares have decreased by 59.3% and is now trading at $1.44.

Geron Corporation (NASDAQ:GERN) issued its quarterly earnings results on Wednesday, May, 7th. The biopharmaceutical company reported ($0.03) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.01. The firm's revenue was up 12927.3% compared to the same quarter last year.
Read the conference call transcript
.

Shares of GERN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Geron investors own include Meta Platforms (META), NVIDIA (NVDA), Tesla (TSLA), Novavax (NVAX), Advanced Micro Devices (AMD), Intel (INTC) and Bristol Myers Squibb (BMY).

Company Calendar

Last Earnings
5/07/2025
Today
7/09/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:GERN
CIK
886744
Employees
70
Year Founded
N/A

Price Target and Rating

High Price Target
$9.00
Low Price Target
$1.50
Potential Upside/Downside
+251.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.78
Research Coverage
9 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$174.57 million
Net Margins
-119.54%
Pretax Margin
-119.54%

Debt

Sales & Book Value

Annual Sales
$76.99 million
Price / Cash Flow
N/A
Book Value
$0.46 per share
Price / Book
3.13

Miscellaneous

Free Float
589,659,000
Market Cap
$917.16 million
Optionable
Optionable
Beta
0.64

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:GERN) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners